Sectoral Asset Management Inc Aerovate Therapeutics, Inc. Transaction History

Sectoral Asset Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$10.8 - $16.91 $247,050 - $386,816	-22,875 Reduced 10.45%	196,038 $3.06 Million
Q1 2022 May 10, 2022	SELL	$8.25 - $18.33 $526,770 - $1.17 Million	-63,851 Reduced 22.58%	218,913 $4.01 Million
Q4 2021 Feb 11, 2022	SELL	$9.14 - $21.54 $535,631 - $1.26 Million	-58,603 Reduced 17.17%	282,764 $3.33 Million
Q3 2021 Nov 15, 2021	SELL	$11.76 - $22.49 $1.87 Million - $3.57 Million	-158,633 Reduced 31.73%	341,367 $7.16 Million
Q2 2021 Aug 16, 2021	BUY	$22.83 - $22.83 $11.4 Million - $11.4 Million	500,000 New	500,000 $11.4 Million

28.1M

116K

26.6K

Ticker AVTE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,448,100
Market Cap $65M
Description
Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. The company focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which ...

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Sectoral Asset Management Inc with notifications on news.